SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Aclaris Therapeutics Prices $50 Million Stock and Warrant Offering

Aclaris Therapeutics priced a $50 million offering of common stock and pre-funded warrants.

ACRS
SquawkNews Desk 2 updates Updated Oct 27, 2026, 10:46 AM UTC

Story updates

10:44:24 AM UTC
SquawkNews
ACLARIS THERAPEUTICS - PRICES 7,785,714 SHARES OF COMMON STOCK AT $3.5 PER SHARE
10:46:22 AM UTC
SquawkNews
Aclaris priced an underwritten offering of 7.79 mln common shares at $3.50/share and pre-funded warr

Related stories

Teck Resources Publishes Q3 2026 Earnings Call Transcript M impact | EQUITY | Oct 29, 2026, 11:59 PM UTC Aecon Group Reports Quarterly Results Through September 30 Aecon Group reported results for the quarter ended September 30. Figures are in Canadian dollars unless otherwise stated. M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC Eastman Chemical Reports Quarterly Results Through September 30 The LSEG-generated earnings summary covers Eastman Chemical Co.'s quarter ended September 30. M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC Coles Shares Fall 12% After Sales Disappoint, Fuel Costs Threaten Profits Coles said supermarket same-store sales rose 2.7% in the 13 weeks through Sept. 27 and warned that rising fuel costs would hurt profits. Its shares fell 12%, putting them on course M impact | EQUITY | Oct 29, 2026, 11:57 PM UTC TFS Financial Reports Quarterly Results TFS Financial Corp reported results for the quarter ended September 30. M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC FirstCash Shares Decline 14.75% as Law Firm Investigates Potential Securities Fraud The Law Offices of Frank R. Cruz says it continues investigating potential securities fraud after a 14.75% decline in FirstCash Holdings shares. M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC